Sionna Therapeutics Inc. SION
Super Investor & Insider
2
Fondi che lo detengono
#511
Rank consenso
2.9%
% dei portafogli
$129.2M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Viking Global Investors · Viking Global Investors | 0.36% | — | 3,195,181 | $128.1M |
| Polen Capital Management · Polen Capital Management | 0.01% | Reduce 14.34% | 26,775 | $1.1M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Sionna Therapeutics Inc. is a biotechnology company focused on developing innovative therapies to address cystic fibrosis, a genetic disorder that impacts the respiratory and digestive systems. The company's primary goal is to advance research and therapeutic approaches that restore the balance of chloride ions, pivota…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees59
TickerSION
Statistics
Market Cap$1.62B
Revenue (TTM)—
Net Income-$75.3M
Net Margin—
EPS$-1.86
P/E-19.15
P/S—
P/B5.64
EV/EBITDA-13.52
ROE-26.7%
Dividend Yield—
Price$36.04
Data: Twelve Data · Revenue = mcap / P/S